Aduro BioTech Inc., of Berkeley, Calif., has received three grants relating to its Listeria monocytogenes vaccine platform. The grants from the Defense Threat Reduction Agency and the National Institutes of Health will support development of vaccines for tularemia, hepatitis B and melanoma.